FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890581544> ?p ?o ?g. }

• W2890581544 endingPage "e0203453" @default.
• W2890581544 startingPage "e0203453" @default.
• W2890581544 abstract "We conducted a retrospective study based on composite endpoints for treatment failure to evaluate the effect of pharmacist-led VCM initial dose planning for Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia patients.A retrospective cohort study was performed between pharmacist intervention and non-intervention groups. In this study, four types of failure were defined as the composite endpoint. When any one of the following failures occurred: 1) Death within 30 days from the start of VCM therapy, 2) Positive blood culture 7 days after the start of VCM therapy, 3) Change of VCM to another anti-MRSA agent, and 4) Development of nephrotoxicity, we considered that VCM treatment had failed. Survival time analysis was conducted with the Kaplan-Meier method and Cox's proportional hazard model that included seven predefined parameters: pharmacist intervention, age, sex, weight, baseline VCM trough concentration, Charlson Comorbidity Index (CCI), and Pitt Bacteremia score (PBS). The effect of pharmacist intervention was studied as the survival probability estimated from the period of time from the start of VCM administration to the earliest failure.The survival rate at 30 days after starting VCM therapy, at the end of follow-up, was 53.1 and 82.1% in the non-intervention and intervention groups, respectively. A significant survival time prolongation was noted in the intervention group (p = 0.011, log rank test). Among the seven parameters, only pharmacist intervention was significantly different and its hazard ratio was 0.26 (p = 0.014). The survival probability of the intervention group was higher than that of the non-intervention group for the time to each failure. In subgroup analyses, a significant difference was noted in male patients between the intervention and non-intervention groups (p = 0.005). Age was categorized into those under and over 65 years old. For those over 65 years old, a significant difference was shown between the groups (p = 0.018).To our knowledge, this is the first study to evaluate the failure of VCM treatment based on the composite endpoint. Pharmacist intervention through the initial VCM dose planning could maintain a balance between the efficacy and safety of VCM treatment and might avoid treatment failure for patients with MRSA bacteremia. Further investigations with large sample sizes are required to confirm our findings." @default.
• W2890581544 created "2018-09-27" @default.
• W2890581544 creator A5007218728 @default.
• W2890581544 creator A5013156807 @default.
• W2890581544 creator A5074382095 @default.
• W2890581544 creator A5045731653 @default.
• W2890581544 creator A5081310242 @default.
• W2890581544 date "2018-09-06" @default.
• W2890581544 modified "2023-10-10" @default.
• W2890581544 title "Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus" @default.
• W2890581544 cites W1619915988 @default.
• W2890581544 cites W1972470346 @default.
• W2890581544 cites W1997967615 @default.
• W2890581544 cites W2006537115 @default.
• W2890581544 cites W2011312924 @default.
• W2890581544 cites W2018660616 @default.
• W2890581544 cites W2035742693 @default.
• W2890581544 cites W2052039887 @default.
• W2890581544 cites W2095930366 @default.
• W2890581544 cites W2099365065 @default.
• W2890581544 cites W2105064679 @default.
• W2890581544 cites W2106444474 @default.
• W2890581544 cites W2106925893 @default.
• W2890581544 cites W2112191002 @default.
• W2890581544 cites W2112459888 @default.
• W2890581544 cites W2114585210 @default.
• W2890581544 cites W2116476574 @default.
• W2890581544 cites W2116736766 @default.
• W2890581544 cites W2116745948 @default.
• W2890581544 cites W2121656227 @default.
• W2890581544 cites W2127277701 @default.
• W2890581544 cites W2133120422 @default.
• W2890581544 cites W2133613588 @default.
• W2890581544 cites W2133902131 @default.
• W2890581544 cites W2152771638 @default.
• W2890581544 cites W2158657903 @default.
• W2890581544 cites W2160244430 @default.
• W2890581544 cites W2241813817 @default.
• W2890581544 cites W2328476376 @default.
• W2890581544 cites W2531562607 @default.
• W2890581544 cites W2738010308 @default.
• W2890581544 cites W4211003757 @default.
• W2890581544 cites W4245675856 @default.
• W2890581544 doi "https://doi.org/10.1371/journal.pone.0203453" @default.
• W2890581544 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6126860" @default.
• W2890581544 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30188918" @default.
• W2890581544 hasPublicationYear "2018" @default.
• W2890581544 type Work @default.
• W2890581544 sameAs 2890581544 @default.
• W2890581544 citedByCount "14" @default.
• W2890581544 countsByYear W28905815442019 @default.
• W2890581544 countsByYear W28905815442020 @default.
• W2890581544 countsByYear W28905815442021 @default.
• W2890581544 countsByYear W28905815442022 @default.
• W2890581544 crossrefType "journal-article" @default.
• W2890581544 hasAuthorship W2890581544A5007218728 @default.
• W2890581544 hasAuthorship W2890581544A5013156807 @default.
• W2890581544 hasAuthorship W2890581544A5045731653 @default.
• W2890581544 hasAuthorship W2890581544A5074382095 @default.
• W2890581544 hasAuthorship W2890581544A5081310242 @default.
• W2890581544 hasBestOaLocation W28905815441 @default.
• W2890581544 hasConcept C104863432 @default.
• W2890581544 hasConcept C10515644 @default.
• W2890581544 hasConcept C126322002 @default.
• W2890581544 hasConcept C159110408 @default.
• W2890581544 hasConcept C167135981 @default.
• W2890581544 hasConcept C168563851 @default.
• W2890581544 hasConcept C203092338 @default.
• W2890581544 hasConcept C207103383 @default.
• W2890581544 hasConcept C2778980435 @default.
• W2890581544 hasConcept C2779443120 @default.
• W2890581544 hasConcept C2779457091 @default.
• W2890581544 hasConcept C2779489039 @default.
• W2890581544 hasConcept C44249647 @default.
• W2890581544 hasConcept C501593827 @default.
• W2890581544 hasConcept C50382708 @default.
• W2890581544 hasConcept C523546767 @default.
• W2890581544 hasConcept C54355233 @default.
• W2890581544 hasConcept C71924100 @default.
• W2890581544 hasConcept C86803240 @default.
• W2890581544 hasConcept C89423630 @default.
• W2890581544 hasConceptScore W2890581544C104863432 @default.
• W2890581544 hasConceptScore W2890581544C10515644 @default.
• W2890581544 hasConceptScore W2890581544C126322002 @default.
• W2890581544 hasConceptScore W2890581544C159110408 @default.
• W2890581544 hasConceptScore W2890581544C167135981 @default.
• W2890581544 hasConceptScore W2890581544C168563851 @default.
• W2890581544 hasConceptScore W2890581544C203092338 @default.
• W2890581544 hasConceptScore W2890581544C207103383 @default.
• W2890581544 hasConceptScore W2890581544C2778980435 @default.
• W2890581544 hasConceptScore W2890581544C2779443120 @default.
• W2890581544 hasConceptScore W2890581544C2779457091 @default.
• W2890581544 hasConceptScore W2890581544C2779489039 @default.
• W2890581544 hasConceptScore W2890581544C44249647 @default.
• W2890581544 hasConceptScore W2890581544C501593827 @default.
• W2890581544 hasConceptScore W2890581544C50382708 @default.
• W2890581544 hasConceptScore W2890581544C523546767 @default.
• W2890581544 hasConceptScore W2890581544C54355233 @default.

• next